W.A.J.J. Hermens

850 total citations
20 papers, 678 citations indexed

About

W.A.J.J. Hermens is a scholar working on Pediatrics, Perinatology and Child Health, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, W.A.J.J. Hermens has authored 20 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 4 papers in Pharmaceutical Science and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in W.A.J.J. Hermens's work include Advanced Drug Delivery Systems (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). W.A.J.J. Hermens is often cited by papers focused on Advanced Drug Delivery Systems (4 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Pharmaceutical Practices and Patient Outcomes (3 papers). W.A.J.J. Hermens collaborates with scholars based in Netherlands, China and Sweden. W.A.J.J. Hermens's co-authors include F.W.H.M. Merkus, J. Coos Verhoef, J. Coos Verhoef, P. M. Hooymans, Stefan Romeijn, Nicolaas Schipper, Hieronymus J. Derijks, Toine C. G. Egberts, J.M.W.M. Merkus and Peter A. G. M. De Smet and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

W.A.J.J. Hermens

19 papers receiving 635 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W.A.J.J. Hermens Netherlands 12 260 148 89 87 83 20 678
Barbara Schug Germany 16 272 1.0× 151 1.0× 56 0.6× 70 0.8× 13 0.2× 47 991
Esther V. Uijtendaal Netherlands 10 125 0.5× 131 0.9× 16 0.2× 62 0.7× 127 1.5× 18 689
Francesca Baratta Italy 14 74 0.3× 87 0.6× 45 0.5× 24 0.3× 61 0.7× 39 601
DG Waller United Kingdom 17 61 0.2× 79 0.5× 78 0.9× 37 0.4× 23 0.3× 28 920
Parviz Mojaverian United States 18 211 0.8× 132 0.9× 50 0.6× 48 0.6× 8 0.1× 41 886
Gérard Flesch Switzerland 19 94 0.4× 102 0.7× 96 1.1× 80 0.9× 11 0.1× 30 1.3k
AG Renwick United Kingdom 13 57 0.2× 57 0.4× 75 0.8× 57 0.7× 22 0.3× 26 787
R. Dahlqvist Sweden 23 57 0.2× 158 1.1× 39 0.4× 81 0.9× 67 0.8× 45 1.3k
Toshinobu Aoyama Japan 17 115 0.4× 107 0.7× 23 0.3× 44 0.5× 17 0.2× 81 837
SHIKIFUMI KITAZAWA Japan 14 107 0.4× 163 1.1× 19 0.2× 31 0.4× 13 0.2× 61 579

Countries citing papers authored by W.A.J.J. Hermens

Since Specialization
Citations

This map shows the geographic impact of W.A.J.J. Hermens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W.A.J.J. Hermens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W.A.J.J. Hermens more than expected).

Fields of papers citing papers by W.A.J.J. Hermens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W.A.J.J. Hermens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W.A.J.J. Hermens. The network helps show where W.A.J.J. Hermens may publish in the future.

Co-authorship network of co-authors of W.A.J.J. Hermens

This figure shows the co-authorship network connecting the top 25 collaborators of W.A.J.J. Hermens. A scholar is included among the top collaborators of W.A.J.J. Hermens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W.A.J.J. Hermens. W.A.J.J. Hermens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derijks, Hieronymus J., et al.. (2024). Sulfamethoxazole-Trimethoprim-Induced Hyperkalemia in Hospitalized Patients Using Potassium-Sparing Drugs: An Observational Study. The Senior Care Pharmacist. 39(7). 259–266.
2.
Grootens, Koen P., et al.. (2023). Capillary blood sampling for the determination of clozapine concentrations: analytical validation and patient experience. International Clinical Psychopharmacology. 39(1). 23–28. 5 indexed citations
3.
Marum, Rob J. van, et al.. (2018). Deprescribing in Newly Admitted Psychogeriatric Nursing Facility Patients. The Consultant Pharmacist. 33(6). 331–338. 5 indexed citations
4.
Egberts, Toine C. G., Patricia M. L. A. van den Bemt, Anne J. Leendertse, et al.. (2015). The Association Between Potentially Inappropriate Prescribing and Medication-Related Hospital Admissions in Older Patients: A Nested Case Control Study. Drug Safety. 39(1). 79–87. 51 indexed citations
5.
Derijks, Hieronymus J., et al.. (2011). Comparison of a basic and an advanced pharmacotherapy-related clinical decision support system in a hospital care setting in the Netherlands. Journal of the American Medical Informatics Association. 19(1). 66–71. 49 indexed citations
6.
Hermens, W.A.J.J., et al.. (2008). Drug treatment-related factors of inadequate seizure control. Epilepsy & Behavior. 13(3). 545–548. 6 indexed citations
7.
Puijenbroek, Eugène van, et al.. (2008). Influence of Chemical Structure on Hypersensitivity Reactions Induced by Antiepileptic Drugs. Drug Safety. 31(8). 695–702. 35 indexed citations
8.
Hermens, W.A.J.J., et al.. (2006). Changes in medication associated with epilepsy‐related hospitalisation: a case‐crossover study. Pharmacoepidemiology and Drug Safety. 16(2). 189–196. 10 indexed citations
9.
Merkus, F.W.H.M., Nicolaas Schipper, W.A.J.J. Hermens, Stefan Romeijn, & J. Coos Verhoef. (1993). Absorption enhancers in nasal drug delivery: efficacy and safety. Journal of Controlled Release. 24(1-3). 201–208. 104 indexed citations
10.
Hermens, W.A.J.J., et al.. (1992). Intranasal administration of estradiol in combination with progesterone to oophorectomized women: a pilot study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 43(1). 65–70. 25 indexed citations
11.
Hermens, W.A.J.J.. (1992). Delivery of hormones: some new concepts. Pharmacy World & Science. 14(4). 253–257. 2 indexed citations
12.
Hermens, W.A.J.J., et al.. (1991). Intranasal estradiol administration to oophorectomized women. European Journal of Obstetrics & Gynecology and Reproductive Biology. 40(1). 35–41. 36 indexed citations
13.
Hermens, W.A.J.J., P. M. Hooymans, J. Coos Verhoef, & F.W.H.M. Merkus. (1990). Effects of Absorption Enhancers on Human Nasal Tissue Ciliary Movement in Vitro. Pharmaceutical Research. 7(2). 144–146. 64 indexed citations
14.
Hermens, W.A.J.J., et al.. (1990). Nasal Absorption Enhancement of 17β-Estradiol by Dimethyl-β-Cyclodextrin in Rabbits and Rats. Pharmaceutical Research. 7(5). 500–503. 62 indexed citations
15.
Janknegt, Robert, et al.. (1990). Stability of Amphotericin B in CAPD Fluid. Peritoneal Dialysis International. 10(4). 287–289. 6 indexed citations
16.
Hermens, W.A.J.J., et al.. (1989). Absorption Enhancement of Intranasally Administered Insulin by Sodium Taurodihydrofusidate (STDHF) in Rabbits and Rats. Pharmaceutical Research. 6(10). 853–856. 57 indexed citations
17.
Hermens, W.A.J.J. & F.W.H.M. Merkus. (1987). The Influence of Drugs on Nasal Ciliary Movement. Pharmaceutical Research. 4(6). 445–449. 61 indexed citations
18.
Duchateau, Guus, J. Zuidema, W.A.J.J. Hermens, & F.W.H.M. Merkus. (1986). In vitro ciliotoxicity of propranolol isomers. International Journal of Pharmaceutics. 31(3). 275–276. 5 indexed citations
19.
Hermens, W.A.J.J., et al.. (1985). New insights into the pharmacokinetics of spironolactone. Clinical Pharmacology & Therapeutics. 38(4). 469–474. 68 indexed citations
20.
Hermens, W.A.J.J., et al.. (1985). Determination of the serum concentration of spironolactone and its metabolites by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 341(2). 279–285. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Schug Breakdown of academic impact, for papers by Esther V. Uijtendaal Breakdown of academic impact, for papers by Francesca Baratta Breakdown of academic impact, for papers by DG Waller Breakdown of academic impact, for papers by Parviz Mojaverian Breakdown of academic impact, for papers by Gérard Flesch Breakdown of academic impact, for papers by AG Renwick Breakdown of academic impact, for papers by R. Dahlqvist Breakdown of academic impact, for papers by Toshinobu Aoyama Breakdown of academic impact, for papers by SHIKIFUMI KITAZAWA
Rankless by CCL
2026